Literature DB >> 22975063

Rikkunshito as a ghrelin enhancer.

Hiroshi Takeda1, Shuichi Muto, Koji Nakagawa, Shunsuke Ohnishi, Chiharu Sadakane, Yayoi Saegusa, Miwa Nahata, Tomohisa Hattori, Masahiro Asaka.   

Abstract

Rikkunshito is a kampo herbal medicine which is widely used in Japan for the treatment of the upper gastrointestinal symptoms of patients with functional dyspepsia, gastroesophageal reflux disease, dyspeptic symptoms of postgastrointestinal surgery patients, and chemotherapy-induced dyspepsia in cancer patients. Recently, very unique characteristics of rikkunshito have been unveiled; oral administration of rikkunshito potentiates orexigenic action of ghrelin through several different mechanisms. In addition, several lines of evidence obtained from both animal and human studies indicate that rikkunshito can be an attractive and promising therapeutic option for the anorectic conditions including cisplatin-induced dyspepsia, anorexia of aging, stress-induced hypophagia, and cancer cachexia-anorexia syndrome. In this chapter, we highlight the orexigenic effect of rikkunshito with a special focus on its interaction with ghrelin signaling system.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22975063     DOI: 10.1016/B978-0-12-381272-8.00021-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  11 in total

1.  Preventive effect of rikkunshito on gastric motor function inhibited by L-dopa in rats.

Authors:  Lixin Wang; Sachiko Mogami; Hiroshi Karasawa; Chihiro Yamada; Seiichi Yakabi; Koji Yakabi; Tomohisa Hattori; Yvette Taché
Journal:  Peptides       Date:  2014-03-11       Impact factor: 3.750

Review 2.  Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment.

Authors:  Sumbul Ali; Ji-an Chen; Jose M Garcia
Journal:  Curr Opin Support Palliat Care       Date:  2013-12       Impact factor: 2.302

3.  Patterns of Brain Activation and Meal Reduction Induced by Abdominal Surgery in Mice and Modulation by Rikkunshito.

Authors:  Lixin Wang; Sachiko Mogami; Seiichi Yakabi; Hiroshi Karasawa; Chihiro Yamada; Koji Yakabi; Tomohisa Hattori; Yvette Taché
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

4.  Effects of Kampo on functional gastrointestinal disorders.

Authors:  Takakazu Oka; Hirokuni Okumi; Shinji Nishida; Takashi Ito; Shinichi Morikiyo; Yoko Kimura; Masato Murakami
Journal:  Biopsychosoc Med       Date:  2014-01-21

5.  Kampo medicine for palliative care in Japan.

Authors:  Hirokuni Okumi; Atsuko Koyama
Journal:  Biopsychosoc Med       Date:  2014-01-22

6.  Ghrelin enhancer, rikkunshito, improves postprandial gastric motor dysfunction in an experimental stress model.

Authors:  Y Harada; S Ro; M Ochiai; K Hayashi; E Hosomi; N Fujitsuka; T Hattori; K Yakabi
Journal:  Neurogastroenterol Motil       Date:  2015-06-18       Impact factor: 3.598

Review 7.  The Role of Ghrelin and Ghrelin Signaling in Aging.

Authors:  Marie Amitani; Haruka Amitani; Kai-Chun Cheng; Timothy Sean Kairupan; Nanami Sameshima; Ippei Shimoshikiryo; Kimiko Mizuma; Natasya Trivena Rokot; Yasuhito Nerome; Tetsuhiro Owaki; Akihiro Asakawa; Akio Inui
Journal:  Int J Mol Sci       Date:  2017-07-12       Impact factor: 5.923

8.  Peripheral α2-β1 adrenergic interactions mediate the ghrelin response to brain urocortin 1 in rats.

Authors:  Koji Yakabi; Yumi Harada; Kiyoshige Takayama; Shoki Ro; Mitsuko Ochiai; Seiichi Iizuka; Tomohisa Hattori; Lixin Wang; Yvette Taché
Journal:  Psychoneuroendocrinology       Date:  2014-09-16       Impact factor: 4.905

9.  Herbal medicines for cancer cachexia: protocol for a systematic review.

Authors:  Bongki Park; Ji Hee Jun; Jeeyoun Jung; Sooseong You; Myeong Soo Lee
Journal:  BMJ Open       Date:  2014-06-03       Impact factor: 2.692

10.  Liu Jun Zi Tang-A Potential, Multi-Herbal Complementary Therapy for Chemotherapy-Induced Neurotoxicity.

Authors:  Chun-Tang Chiou; Kaw-Chen Wang; Ying-Chen Yang; Chuen-Lin Huang; Sien-Hung Yang; Yao-Haur Kuo; Nai-Kuei Huang
Journal:  Int J Mol Sci       Date:  2018-04-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.